Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.
- DOI
- 10.1080/09546634.2025.2600241
- Published
- 2026 Dec
- Container
- The Journal of dermatological treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/09546634.2025.2600241,
title = {Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.},
author = {Bonifati C and Argenziano G and Lembo S and Richetta AG and Romanelli M and Satolli F and Corazza M and Atzori L and Lasagni C and Potenza C and Savoia P and Bardazzi F and Di Lernia VG and Galluzzo M and Megna M and Giofrè C and Zichichi L and Guarneri C and Pallotta S and Fargnoli MC and Loconsole F and Offidani A and Burlando M and Piaserico S and Peris K and Papini M and Carrera CG and Prignano F and Bongiorno MR and Dapavo P and Stingeni L and Donini M and Micali G and Rongioletti F and Stinco G and Saibene F and Gramiccia T and Costanzo A},
year = {2026},
journal = {The Journal of dermatological treatment},
doi = {10.1080/09546634.2025.2600241},
url = {https://doi.org/10.1080/09546634.2025.2600241}
}RIS
TY - JOUR TI - Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study. AU - Bonifati C AU - Argenziano G AU - Lembo S AU - Richetta AG AU - Romanelli M AU - Satolli F AU - Corazza M AU - Atzori L AU - Lasagni C AU - Potenza C AU - Savoia P AU - Bardazzi F AU - Di Lernia VG AU - Galluzzo M AU - Megna M AU - Giofrè C AU - Zichichi L AU - Guarneri C AU - Pallotta S AU - Fargnoli MC AU - Loconsole F AU - Offidani A AU - Burlando M AU - Piaserico S AU - Peris K AU - Papini M AU - Carrera CG AU - Prignano F AU - Bongiorno MR AU - Dapavo P AU - Stingeni L AU - Donini M AU - Micali G AU - Rongioletti F AU - Stinco G AU - Saibene F AU - Gramiccia T AU - Costanzo A PY - 2026 JO - The Journal of dermatological treatment DO - 10.1080/09546634.2025.2600241 UR - https://doi.org/10.1080/09546634.2025.2600241 ER -
APA
C, B., G, A., S, L., AG, R., M, R., F, S., M, C., L, A., C, L., C, P., P, S., F, B., VG, D. L., M, G., M, M., C, G., L, Z., C, G., S, P., MC, F., F, L., A, O., M, B., S, P., K, P., M, P., CG, C., F, P., MR, B., P, D., L, S., M, D., G, M., F, R., G, S., F, S., T, G., & A, C. (2026). Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.. The Journal of dermatological treatment. https://doi.org/10.1080/09546634.2025.2600241
Source records
- pubmed · retrieved 2026-09-27T07:52:24.575Z